Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.
These big pharma stocks have something for everyone. Income investors love the dividends Eli Lilly and Co. (NYSE: LLY) and Merck & Co., Inc. (NYSE: MRK) pay each quarter, while dreams of successful new drug launches attract growth-minded investors.
Lilly's stock price has risen in line with the broader market this year, but Merck tanked in October. Let's take a closer look at the threats and opportunities facing both to see which of these big pharma stocks is the better pick right now.
Image source: Getty Images.
Source: Fool.com
Eli Lilly Corp. Stock
€741.20
2.940%
The stock is an absolute favorite of our community with 51 Buy predictions and no Sell predictions.
With a target price of 776 € there is a slightly positive potential of 4.7% for Eli Lilly Corp. compared to the current price of 741.2 €.
